Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals - Guidance document (English, HTML)
Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals - Guidance document: English HTML file. From Health Canada, updated Oct 2022. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2022-10-21
This is a public health concern resulting in significant costs to the health care system as well as individual impacts on Canadians. Health Canada's monitoring of therapeutic product safety plays a vital role in public health and patient safety, providing health care providers and patients with the most up-to-date knowledge for decision making. It also provides Health Canada with information needed to monitor the benefit-risk ratio of products and act to protect Canadians where appropriate.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file